Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study.

Title: Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study.
Authors: Dramowski, Angela; Ong'ayo, Gerald; Rehman, Andrea M; Whitelaw, Andrew; Labi, Appiah-Korang; Obeng-Nkrumah, Noah; Ndir, Awa; Magwenzi, Marcelyn T; Onyedibe, Kenneth; Wolkewitz, Martin; de Kraker, Marlieke EA; Scott, J Anthony G; Aiken, Alexander M; MBIRA study collaborators
Publication Year: 2020
Collection: London School of Hygiene & Tropical Medicine: LSHTM Research Online
Description: BACKGROUND: Bloodstream infections (BSI) caused by Enterobacteriaceae show increasing frequency of resistance to third-generation cephalosporin (3GC) antibiotics on the African continent but the mortality impact has not been quantified. METHODS: We used historic data from six African hospitals to assess the impact of 3GC resistance on clinical outcomes in Escherichia coli and Klebsiella pneumoniae BSI. We matched each bacteraemic patient to two uninfected patients. We compared outcomes between 3GC-susceptible and 3GC-resistant BSI and their respective uninfected controls using Cox regression models. RESULTS: For 1431 E. coli BSI patients, we matched 1152 (81%) 3GC-susceptible and 279 (19%) 3GC-resistant cases to 2263 and 546 uninfected inpatient controls. For 1368 K. pneumoniae BSI patients, we matched 502 (37%) 3GC-susceptible and 866 (63%) 3GC-resistant cases to 982 and 1656 uninfected inpatient controls. We found that 3GC-resistant E. coli had similar hazard ratios (HRs) for in-hospital mortality over their matched controls as compared to susceptible infections over their controls (ratio of HRs 1.03, 95% CI 0.73-1.46). Similarly, 3GC-resistance in K. pneumoniae BSI was not associated with mortality (ratio of HR 1.10, 95% CI 0.80-1.52). Estimates of mortality impact varied by site without a consistent pattern. CONCLUSIONS: In a retrospective analysis, including the use of matched uninfected patients, there did not appear to be an impact of 3GC-resistance on mortality in E. coli or K. pneumoniae BSI in African hospitals, as compared with susceptible BSI with equivalent species. Better information on the actual use of antibiotics in treating infections in African hospitals would improve these impact estimates.
Document Type: article in journal/newspaper
File Description: text
Language: English
Relation: https://researchonline.lshtm.ac.uk/id/eprint/4659099/1/Dramowski%20A%20JAC-AMR%202021.pdf; Dramowski, Angela; Ong'ayo, Gerald; Rehman, Andrea M ORCID logo; Whitelaw, Andrew; Labi, Appiah-Korang; Obeng-Nkrumah, Noah; Ndir, Awa; Magwenzi, Marcelyn T; Onyedibe, Kenneth; Wolkewitz, Martin; +4 more.de Kraker, Marlieke EAORCID logo; Scott, J Anthony G ORCID logo; Aiken, Alexander M ORCID logo; and MBIRA study collaborators (2020) Mortality attributable to third-generation cephalosporin resistance in Gram-negative bloodstream infections in African hospitals: a multi-site retrospective study. JAC-Antimicrobial Resistance, 3 (1). dlaa130-. DOI:10.1093/jacamr/dlaa130
DOI: 10.1093/jacamr/dlaa130
Availability: https://researchonline.lshtm.ac.uk/id/eprint/4659099/; https://doi.org/10.1093/jacamr/dlaa130
Rights: cc_by_nc_nd
Accession Number: edsbas.E61BACB3
Database: BASE